HR Execs on the Move

Shire

www.shire.com

 
At Shire, we enable people with life altering conditions to lead better lives. We focus on developing and delivering innovative treatments for patients with rare diseases and other specialty conditions.To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.shire.com
  • 300 Shire Way
    Lexington, MA USA 02421
  • Phone: 617.349.0200

Executives

Name Title Contact Details
Julie Person
 Vice President of Global Talent Management Profile
Megan Sullivan
 Head of Learning and Development Profile
Patricia Robertson
 Head of Learning and Development Innovation and Knowledge Management Profile
Niclas Nordensved
 Head of Learning and Development Profile
Stephanie Engels
 Head of Human Resources Profile

Similar Companies

Sucampo

Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG.

Enanta

Enanta Pharmaceuticals is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections. Two protease inhibitors, glecaprevir and paritaprevir, discovered and developed through Enanta`s collaboration with AbbVie, have now been approved around the world as part of AbbVie`s regimens for the treatment of hepatitis C virus (HCV) infection. The leading regimen is sold under the tradenames MAVYRET™ (U.S.) and MAVIRET™ (ex-U.S.) (glecaprevir/pibrentasvir). Royalties from the AbbVie collaboration are helping to fund Enanta`s research and development efforts, which are currently focused on the following disease targets: respiratory syncytial virus (RSV), hepatitis B virus (HBV), SARS-CoV-2 (COVID-19) and human metapneumovirus (hMPV).

Metrics

Metrics provides pharmaceutical product development including pre-formulation studies, formulation development, clinical trial batch manufacturing and clinical trial batch packaging and labeling for non-sterile dosage forms. In addition, Metrics

Advanced Urology

Advanced Urology provides cutting-edge Vasectomy, Circumcision, InterStim, Urolift, Cytoscopy, TURP, Vasectomy Reversal & IPP. Contact us today for an initial consult.

Teon Therapeutics

Teon Therapeutics is a global start-up bio-pharmaceutical company located in Redwood City, CA.